Clinical Trials
3 trialsNCT00036790 2019-12-17
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT00089284 2019-08-14
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
Northwestern University
Phase 1/2 Terminated
NCT00086034 2007-05-15
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Pharmacyclics LLC.
Phase 2 Completed